SomaLogic, Inc.
SLGC · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 7.7% | 0.4% | 8.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 47.2% | 45.4% | 39.6% | 31.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -82.5% | -145.3% | -197.2% | -265% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -100.5% | -121% | -167.8% | -261.6% |
| EPS Diluted | -0.12 | -0.13 | -0.18 | -0.26 |
| % Growth | 7.7% | 27.8% | 30.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |